Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telemonitoring to Optimize Medication Titration for Heart Failure (TOM-HF): a Feasibility Study

NCT07016815 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07016815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07016815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telemonitoring to Optimize Medication Titration for Heart Failure (TOM-HF): a Feasibility Study
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2025
Completion date
February 28, 2029
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure with reduced left ventricular ejection fraction